Timothy A. Springer, Director, 10% Owner at Cartesian Therapeutics, Inc. (RNAC), bought 1,834,244 shares at $0.59 ($1.0M) on 2024-03-15, disclosed to the SEC on 2024-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.54 | 648,372 | $350K | 34.4% |
| 2 | $0.54 | 648,372 | $350K | 34.4% |
| 3 | $0.59 | 537,500 | $317K | 31.2% |
| Total | $0.55 avg | 1,834,244 | $1.0M | 100% |
| Filing → |
| TECX | BUY | 2025-04-09 | $17.1M | — | Filing → |
| RNAC | BUY | 2025-03-20 | $2.7M | — | Filing → |
| TECX | BUY | 2025-02-07 | $47.0M | — | Filing → |